Sponsors (13)
Official title: To amend the Public Health Service Act to provide for hospital and insurer price transparency.
Introduced September 26, 2025 by John James · Last progress September 26, 2025
The bill greatly expands price transparency and consumer protections—giving patients, researchers, and plan sponsors better data and stronger safeguards against surprise bills—at the cost of substantial new reporting, IT, and compliance burdens, privacy and proprietary‑information risks, and potentially large penalties that could raise prices or strain smaller providers.
Patients (insured, uninsured, Medicare/Medicaid beneficiaries, and people with chronic conditions) get much clearer, itemized, and more timely price information (EOBs, itemized bills, monthly machine‑readable price files, and real‑time estimate tools) that makes it easier to compare costs and spot billing errors.
Uninsured and self‑pay consumers can see and pay published discounted (or minimum) cash prices accepted as payment in full, protecting cash‑pay patients from chargemaster inflation and surprise collection.
Standardized, machine‑readable price and claims formats across hospitals, labs, imaging centers, ASCs, plans and vendors create data that consumer tools, researchers, regulators, and plan sponsors can use to compare prices, detect overpayments, and improve competition.
Hospitals, providers, labs, imaging centers, ASCs, insurers, and third‑party administrators face substantial new administrative, IT, and compliance costs to produce itemized EOBs, monthly machine‑readable files, estimates, and standardized claim formats — costs that are likely to be passed on to consumers, employers, or taxpayers.
Widespread publication and transfer of granular billing, pricing, and claims data increases privacy and data‑security risks (more PHI surface area, re‑identification potential, and larger data flows), which could expose sensitive patient information if safeguards fail.
Requiring disclosure of payer‑specific negotiated rates, contract formulas, and pricing algorithms risks exposing proprietary commercial terms, undermining bargaining leverage, prompting contract renegotiations, legal challenges, or retaliatory changes that could raise prices or shrink networks.
Based on analysis of 11 sections of legislative text.
Mandates comprehensive price and billing transparency across plans, hospitals, labs, imaging providers, ASCs, and vendors, adds EOB/good‑faith estimate rules, data sharing, and heavy civil penalties.
Requires broad, detailed price and billing transparency across health plans, hospitals, laboratories, imaging providers, ambulatory surgical centers, and certain third‑party service providers, and creates new patient notices, itemized billing rules, data‑sharing duties, and civil penalties. It expands good‑faith estimate and explanation‑of‑benefits requirements, makes many facility and provider prices public in machine‑readable formats, and limits collection actions when billing rules are not followed. Sets phased effective dates (some plan rules apply for plan years beginning Jan 1, 2026; many provider and facility posting requirements start July 1, 2027; some service‑provider reporting begins two years after enactment), directs the HHS Secretary to issue technical rules, and creates significant civil penalties and enforcement authorities for noncompliance.